A new study from Saint Louis University researchers shows that young transplant patients who lose their federally provided insurance coverage are more likely to stop taking necessary anti-rejection drugs, which can increase the risk of losing the transplanted organs.
The study appears in the March issue of Pediatric Transplantation.
“Immunosuppressive drugs that prevent organ rejection are incredibly expensive; sometimes more than $13,000 a year,” says study author Mark Schnitzler, Ph.D., associate professor in the departments of internal medicine and community health at Saint Louis University. “Even for families with insurance, the co-payments can be a huge financial burden.”
Most healthcare costs associated with transplants in the United States – such as critical immunosuppressive drugs – are covered by Medicare for between 36 and 44 months, after which point they are “cut off,” Schnitzler says. If families cannot afford medicine, it can mean losing the transplanted organ or even death.
Young adults from the ages of 18 to 23 face the greatest risk, as nearly a third of this age group lacks medical coverage. Even when families do have coverage after a transplant, it runs out 36 to 44 months post-transplant or when the child reaches adulthood.
Schnitzler and his team studied the medical records of 1,001 children who underwent kidney transplants between 1995 and 2001, half of whom lost their health insurance. He says the results point to a need for better and more comprehensive health insurance.
“Kids with transplanted kidneys who lose their insurance have nine times a greater chance of dying than those who don’t,” he says. “It is critical that we find a way to offer lifetime access to these children and their families so that our society does not continue to prematurely lose this promising pool of young adults.”
For families trying to make some difficult decisions, Schnitzler advises them to retain their insurance, as the cost of insurance is more affordable in the long term than the expense of transplant failure and hospital stays.
“Pediatric transplant recipients have every desire to become independent and useful members of society. To achieve that goal, they need to keep their transplants healthy, and immunosuppressive drugs are essential to ensure that that happens.”
Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious disease.
Rachel Otto | EurekAlert!
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy